Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership Read more about Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards Read more about Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LA's Promise Read more about Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LA's Promise
Amgen to Provide Testimony at FDA Hearing on Biosimilars Read more about Amgen to Provide Testimony at FDA Hearing on Biosimilars
Breakaway From Cancer(R) Launches 'Striking the Balance' Podcast Series to Inspire Action and Change Across the Cancer Continuum Read more about Breakaway From Cancer(R) Launches 'Striking the Balance' Podcast Series to Inspire Action and Change Across the Cancer Continuum
Amgen Announces Webcast of 2010 Third Quarter Financial Results Read more about Amgen Announces Webcast of 2010 Third Quarter Financial Results
Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today Read more about Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting Read more about Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa(R) Read more about Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa(R)
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer Read more about Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer
